Probiotic compositions and process thereof
AssigneeJames Madison Innovations, Inc.
InventorsKevin P. C. Minbiole, Reid Harris
Life of this patent
Estimating the term…
Loading patent…
AssigneeJames Madison Innovations, Inc.
InventorsKevin P. C. Minbiole, Reid Harris
Estimating the term…
Probiotic composition(s) and/or process(es) thereof. Processes may include applying Janthinobacterium, for example Janthinobacterium lividum, over a host and/or host area(s) to minimize microbe(s) and/or maximize therapeutic effects. A process to minimize a microbe may include applying to skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier. Probiotic composition(s) and/or process(es) thereof may include relatively heat tolerant Janthinobacterium lividum which may produce metabolites, for example violacein up to approximately 29° C. Probiotic composition(s) and/or process(es) thereof may include Janthinobacterium lividum between approximately 25×106 and 6.4×107 cells. Probiotic composition(s) and/or process(es) thereof may include Janthinobacterium lividum which has and/or produces between approximately 18 μM and 129 μM of violacein. Probiotic composition(s) and/or process(es) thereof may include a stimulant to maximize metabolites. A process to minimize a microbe may include removing a portion of resident microbes with a sanitizer. Janthinobacterium lividum may be in lysed form.
A process to minimize a microbe colony growth comprising applying to human skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier.
A process to minimize Tricophyton rubrum colony growth comprising applying to skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier.
A process to minimize a microbe colony growth comprising applying to skin a composition including isolated Janthinobacterium lividum, a stimulant to maximize at least violacein, and a pharmaceutically acceptable carrier.
A process to minimize a microbe colony growth comprising applying to skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier, wherein said Janthinobacterium lividum is in a lysed form.
Dependencies are inferred from the claim text.